Definition
Krka, officially Krka, d. d., is a Slovenian multinational pharmaceutical company that produces prescription medicines, non‑prescription (over‑the‑counter) products, animal health preparations, and a range of consumer health and personal care items.
Overview
Founded in 1954 in the town of Novo Mesto, Slovenia, Krka grew from a small local factory into one of the largest pharmaceutical manufacturers in the region. The company operates a network of production facilities, research and development (R&D) centers, and commercial offices across Europe, Asia, Africa, and the Americas. Krka’s product portfolio includes generic drugs in therapeutic areas such as cardiovascular, central nervous system, respiratory, and gastro‑intestinal disorders, as well as a variety of dermatological and ophthalmological preparations.
Krka is publicly listed on the Ljubljana Stock Exchange (ticker: KRKG) and its shares are held by a mix of institutional investors, private shareholders, and the Slovenian state. The company reports annual revenues exceeding €2 billion and employs more than 10 000 people worldwide. Export markets account for a substantial share of its sales, with the European Union, the United States, Russia, and the Middle East among its major regions.
Etymology/Origin
The company’s name derives from the Krka River, which flows through Novo Mesto and the surrounding Lower Carniola region. The river’s name is of Slavic origin and is widely used for geographic features and institutions in Slovenia.
Characteristics
- Product Range: Generic prescription medicines, OTC products (e.g., analgesics, cough remedies), dietary supplements, veterinary medicines, and personal care items such as skin‑care creams.
- Research & Development: Krka maintains several R&D centers focused on formulation development, bioequivalence studies, and regulatory support. The company collaborates with academic institutions and participates in European Union research programmes.
- Manufacturing: The firm operates multiple GMP‑certified production sites equipped for solid‑dose, liquid‑dose, sterile, and topical formulations. Facilities comply with EU and FDA regulatory standards.
- Market Presence: Products are marketed in more than 70 countries. Krka employs a dual strategy of direct sales in some markets and partnerships or licensing agreements in others.
- Corporate Governance: As a publicly traded entity, Krka adheres to the corporate governance code of the Republic of Slovenia, with a Board of Directors, supervisory board, and an executive management team.
- Sustainability: The company reports on environmental performance, focusing on energy efficiency, waste reduction, and responsible sourcing of raw materials.
Related Topics
- Pharmaceutical industry in Slovenia
- Generic drug manufacturing
- Over‑the‑counter (OTC) medication market
- European Medicines Agency (EMA) regulatory framework
- Ljubljana Stock Exchange
- Krka River (geographic feature)